Search Results 321-330 of 11518 for Cirrhosis
Mayo Clinic researchers seek to understand why some people with nonalcoholic fatty liver disease develop cirrhosis but others do not. Publications. See a ...
Cholangiocarcinoma (bile duct cancer) · Cirrhosis · Esophageal varices · Healthy liver vs. liver cirrhosis · Hepatic encephalopathy · Hepatitis B · Hepatitis C ...
While the liver has a remarkable ability to regenerate, chronic conditions such as cirrhosis, hepatitis and fatty liver disease can quickly progress to end- ...
Liver cirrhosis causes scarring of the liver that increases the risk of hilar cholangiocarcinoma. Bile duct cysts. Bile duct cysts cause bile ducts to change ...
Douglas (Doug) A. Simonetto, M.D., studies complications of cirrhosis and noncirrhotic portal hypertension, with a focus on ascites and hepatorenal syndrome, ...
Cirrhosis and portal hypertension: Treatment for advanced scarring of the liver and associated complications. Steatotic liver disease: Care for individuals ...
Phase 2B Efficacy/Safety Of Ornithine Phenylacetate In Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE) · More about research at Mayo Clinic.
... cirrhosis of the liver. This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Tablet.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.